ADHD, Author Interviews, Heart Disease, Stroke / 07.05.2024

MedicalResearch.com Interview with: [caption id="attachment_61634" align="alignleft" width="150"]Dr Anders HoltDepartment of Cardiology Copenhagen University Hospital–Herlev and Gentofte Gentofte Hospitalsvej Hellerup, Denmark Dr. Holt[/caption] Dr Anders Holt MD PhD Department of Cardiology Copenhagen University Hospital–Herlev and Gentofte Gentofte Hospitalsvej Hellerup, Denmark MedicalResearch.com: What is the background for this study? What types of ADHD treatments were in the study? Response: An increasing number of adults are being diagnosed with ADHD and subsequently treated. Taking the drugs' effect on the sympathetic nervous system into account, it seems relevant to investigate whether treatment could be associated with an elevated long-term risk of cardiovascular disease. The drugs included in the study were methylphenidate, atomoxetine, lisdexamfetamine, dexamfetamine, and modafinil. Owing to the fact that atomoxetine is not a sympathomimetic amine as the others, separate supplementary analyses were carried out for this drug, yielding similar results.
Author Interviews, Brain Injury, Cannabis / 07.05.2024

MedicalResearch.com Interview with: [caption id="attachment_61599" align="alignleft" width="150"]Pamela Maher, PhDResearch Professor Cellular Neurobiology Laboratory SALK Institute for Biologic Studies La Jolla California Dr. Maher[/caption] Pamela Maher, PhD Research Professor Cellular Neurobiology Laboratory SALK Institute for Biologic Studies La Jolla California   MedicalResearch.com: What is the background for this study? Response: Several years ago, we tested several different cannabinoids for protection against the oxytosis/ferroptosis regulated cell death pathway and found CBN (cannabinol) to be one of the most effective. While THC (tetrahydrocannabinol) and CBD (cannabidol) were also quite protective, we wanted to pursue non-psychoactive cannabinoids. Since we are interested in maintaining brain function in the context of aging and disease, we thought that a psychoactive compound could be problematic. In addition, there was already a lot of work on CBD, so we thought we could learn more and contribute more to the field by studying CBN.
Alzheimer's - Dementia, Author Interviews, Brigham & Women's - Harvard, JAMA, Nutrition / 07.05.2024

MedicalResearch.com Interview with: [caption id="attachment_61650" align="alignleft" width="200"]Marta Guasch-Ferré, PhDAssociate Professor and Deputy Head of Section, Section of Epidemiology University of Copenhagen  Group Leader, Novo Nordisk Foundation Center for Basic Metabolic Research  Adjunct Associate Professor, Department of Nutrition Harvard TH Chan School of Public Health  Dr. Guasch-Ferré[/caption] Marta Guasch-Ferré, PhD Associate Professor and Deputy Head of Section, Section of Epidemiology University of Copenhagen Group Leader, Novo Nordisk Foundation Center for Basic Metabolic Research Adjunct Associate Professor, Department of Nutrition Harvard TH Chan School of Public Health MedicalResearch.com: What is the background for this study? Response:  Olive oil is rich in monounsaturated fats and contains compounds with antioxidant activity that may play a protective role for the brain. Olive oil as part of a Mediterranean diet appears to have a beneficial effect against cognitive decline. Higher olive oil intake was previously associated with a lower risk of cardiovascular disease and mortality. But its association with dementia mortality was unknown.
Alzheimer's - Dementia, Author Interviews / 02.05.2024

MedicalResearch.com Interview with: [caption id="attachment_61640" align="alignleft" width="110"]Dr. Li Gan PhDBurton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases
Brain and Mind Research Institute
Weill Cornell Medical College Dr. Li Gan[/caption] Dr. Li Gan PhD Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases Brain and Mind Research Institute Weill Cornell Medical College [caption id="attachment_61627" align="alignleft" width="150"]Shiaoching Gong PhD Helen and Robert Appel Alzheimer’s Disease Institute Feil Family Brain and Mind Research Institute Weill Cornell Medicine, New York, NY Dr. Shiaoching Gong[/caption] Shiaoching Gong PhD Helen and Robert Appel Alzheimer’s Disease Institute Feil Family Brain and Mind Research Institute Weill Cornell Medicine, New York, NY MedicalResearch.com: What is the background for this study? Would you describe the process of making these neurons? Response: Primary tauopathies are a group of progressive neurodegenerative diseases characterized by the pathological aggregation of 3R or 4R tau protein in neurons and/or glial cells, where 4R tauopathies are more common primary tauopathies. The exact pathological mechanisms remain elusive. There are currently no therapies available that can halt or reverse the spread of tau aggregates since the drug effects found in animal models are not always reproduced in human clinical trials. The development of tau therapies from human cells have become urgently needed. Induced human pluripotent stem cells (iPSCs) offer a unique model to better understand pathological mechanisms underlying human diseases and to develop human cell-based therapy. However, a major challenge to study 4R tauopathy is iPSC-derived neurons express very low levels of 4R Tau isoforms making it difficult to study 4R tauopathy and the mutations located in 4R Tau. To address this need, we designed and engineered a robust human iPSC 4R tauopathy model using CRISPR/Cas9 technology. We first introduced specific mutations at the intron-exon 10 junctions and silent mutations within exon 10 to promote exon 10 inclusion, leading the increase of 4R isoforms expression in iPSC-derived neurons. Frontotemporal Dementia (FTD) mutation, P301S located in exon 10 is highly aggregation prone. To generate this human disease 4R tauopathy model, we then introduced this mutation to 4R iPSC to make it a 4RP301S iPSC line.
Author Interviews, Brigham & Women's - Harvard, Mental Health Research, NIH / 19.04.2024

MedicalResearch.com Interview with: [caption id="attachment_61582" align="alignleft" width="135"]Sharon Dekel PhDPrincipal Investigator
Director of the Postpartum Traumatic Stress Disorders Research Program
Department of Psychiatry, Massachusetts General Hospital
Department of Psychiatry, Harvard Medical School
Boston, MA, 02114 Dr. Dekel[/caption] Sharon Dekel PhD Principal Investigator Director of the Postpartum Traumatic Stress Disorders Research Program Department of Psychiatry, Massachusetts General Hospital Department of Psychiatry, Harvard Medical School Boston, MA, 02114 MedicalResearch.com: What is the background for this study? Response: Maternal psychopathologies affect a significant number of American women and are the leading complications of childbirth and a significant contributor to maternal death. Maternal (physical) morbidity in the US remain the highest among all countries in the West, suggesting that some women will have a traumatic childbirth experience. The most common mental illness associated with trauma is posttraumatic stress disorder (PTSD). PTSD stemming from childbirth is estimated to affect 6% of delivering women (https://pubmed.ncbi.nlm.nih.gov/28443054/). In high-risk groups, for example women who have unscheduled Cesareans the rate is estimated at 20% or higher (https://pubmed.ncbi.nlm.nih.gov/31041603/.). Although we screen for postpartum depression in hospitals in the USA there is no screening for what we define as childbirth-related PTSD (CB-PTSD). The overarching goal of the Dekel Lab is to develop novel and patient-friendly screening tools to identify women with this disorder. As importantly traumatic childbirth disproportionality affects Black and Latina women (https://pubmed.ncbi.nlm.nih.gov/35598158/).
Author Interviews, Autism, Nature, Pediatrics / 11.04.2024

MedicalResearch.com Interview with: [caption id="attachment_50547" align="alignleft" width="200"]Andrey Vyshedskiy PhD Boston University, Boston Dr. Vyshedskiy[/caption] Dr. Andrey Vyshedskiy, PhD Founder and CEO of ImagiRation LLC Neuroscientist, Boston University MedicalResearch.com: What is the background for this study? Response: The common intuitive belief is that language comprehension development follows a linear trajectory: children acquire one grammatical rule at a time. Over 20 years ago, Dr. A. Vyshedskiy, predicted that instead of linear development, language should unfold in three steps corresponding to three language comprehension mechanisms of increasing complexity. The study of 31845 autistic individuals, published today in the journal npj Mental Health Research, validates this prediction. The implications of this discovery are reaching far and wide. The traditional definition of language is highly ambiguous. For some philosophers, “language” is equivalent to a “communication system.” Others argue that “language” must be defined more narrowly, in a way that is unique to humans. The results of the new study streamline terminology for describing different language comprehension mechanisms. The ensuing discussion of which language comprehension mechanisms are unique to humans and which are shared with other apes is expected to be most interesting.
Alzheimer's - Dementia, Author Interviews, JAMA, UC Davis / 25.03.2024

MedicalResearch.com Interview with: [caption id="attachment_61484" align="alignleft" width="150"]Charles DeCarli, MD, FAAN, FAHAVictor and Genevieve Orsi Chair in Alzheimer's Research
Distinguished Professor of Neurology
Director, Alzheimer's Disease Research Center
and Imaging of Dementia and Aging (IDeA) Laboratory
Department of Neurology and Center for Neuroscience
University of California at Davis
Sacramento, CA  95817 Dr. DeCarli[/caption] Charles DeCarli, MD, FAAN, FAHA Victor and Genevieve Orsi Chair in Alzheimer's Research Distinguished Professor of Neurology Director, Alzheimer's Disease Research Center and Imaging of Dementia and Aging (IDeA) Laboratory Department of Neurology and Center for Neuroscience University of California at Davis Sacramento, CA  95817   MedicalResearch.com: What is the background for this study? Response: The overall health of the U.S. population has improved dramatically over the last 100 years, Individuals are also living longer resulting in an increasing percentage of the population at risk for Alzheimer’s disease and related dementias (ADRD).  Recent data from the Framingham Heart study, however, finds that dementia incidence may be declining.  While many factors such as greater educational achievement and medical management of vascular risk factors may explain part of this effect, early life environmental differences also likely contribute.
Mental Health Research, Social Issues / 21.03.2024

dating-tirachard-kumtanom-450050Dating is a process in which you get to know another person. If you connect both emotionally and romantically, the relationship could become permanent. However, honesty is needed for this relationship to last. For some people, this might become an issue. If you have taken part in a residential mental health treatment program, should you share that with the other person? If so, when should this be done? The main thing to consider is when this level of intimacy is valued. Don't overshare on a first date, but don't wait until you have been in the relationship for a few years before sharing. When might this be?
ADHD, Author Interviews, Dermatology, JAMA, Mental Health Research / 08.03.2024

MedicalResearch.com Interview with: [caption id="attachment_61409" align="alignleft" width="125"]Dr. Joy Wan M.D., M.S.C.E.Assistant Professor of Dermatology Johns Hopkins University School of Medicine Dr. Wan[/caption] DrJoy Wan M.D., M.S.C.E. Assistant Professor of Dermatology Johns Hopkins University School of Medicine MedicalResearch.com: What is the background for this study? Response: There has been a growing body of literature linking atopic dermatitis with diagnoses such as ADHD and learning disabilities, but studies focusing on symptoms of cognitive impairment (in contrast to relying on reported diagnoses as proxy measures of such) have been fewer and demonstrate inconsistent findings. Thus, we were interested in using data from this nationally representative sample of U.S. children to examine whether atopic dermatitis was associated with symptoms of learning or memory difficulties. Moreover, we wanted to examine how this relationship is influenced by known neurodevelopmental conditions to further characterize whether specific subgroups of children with atopic dermatitis are more susceptible to cognitive impairments.
Mental Health Research / 07.03.2024

psychiatry-psychiatric-care-mentalhealthIn recent years, the field of psychiatric care has undergone a revolutionary transformation. This is because of groundbreaking research that has redefined our understanding of mental health and treatment methodologies. From innovative therapies to advanced diagnostic tools, transformative research has played a pivotal role in reshaping the landscape of psychiatric care. In this article, we will explore the key contributions that researchers have made in this field. We will also talk about how their work is influencing the way mental health is approached and treated.
Author Interviews, Cognitive Issues, COVID -19 Coronavirus, Imperial College, NEJM / 29.02.2024

MedicalResearch.com Interview with: [caption id="attachment_61356" align="alignleft" width="150"]Prof. Adam Hampshire Ph.D.Faculty of Medicine, Department of Brain Sciences Professor in Restorative Neurosciences Imperial College London Prof. Hampshire[/caption] Prof. Adam Hampshire Ph.D. Faculty of Medicine, Department of Brain Sciences Professor in Restorative Neurosciences Imperial College London MedicalResearch.com: What is the background for this study? Response: Cognitive symptoms after coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are well-recognized. Whether objectively measurable cognitive deficits exist and how long they persist are unclear.
Author Interviews, Memory / 14.02.2024

MedicalResearch.com Interview with: [caption id="attachment_61330" align="alignleft" width="125"]Professor Frederic Meunier PhDProfessor and Academic Senior Group/Unit Leader/Supervisor Queensland Brain Institute and Prof. Meunier[/caption] Prof. Frederic Meunier PhD Professor and Academic Senior Group/Unit Leader/Supervisor Queensland Brain Institute and [caption id="attachment_61329" align="alignleft" width="125"]Isaac O Akefe DVM, PhDClem Jones Centre for Ageing Dementia Research Queensland Brain Institute The University of Queensland St Lucia Academy for Medical Education, Medical School Brisbane QLD Australia Dr. Akefe[/caption] Isaac O Akefe DVM, PhD Clem Jones Centre for Ageing Dementia Research Queensland Brain Institute The University of Queensland St Lucia Academy for Medical Education, Medical School Brisbane QLD Australia     MedicalResearch.com: What is the background for this study? Response: The brain is the body’s fattiest organ, with fatty compounds called lipids making up 60% of its weight. Fatty acids are the building blocks of a class of lipids called phospholipids. In our study, we first showed that levels of saturated fatty acids increase in the brain during neuronal communication and long-term memory formation, but we didn’t know what was causing these changes.
Aging, Mental Health Research / 31.01.2024

age-regressionAge regression stands as a captivating psychological occurrence that has piqued the curiosity of scholars, therapists, and individuals alike. It represents a state wherein adults briefly retreat to a more childlike mindset, marked by shifts in conduct, emotions, and cognitive processes. This article delves into the concept of age regression, its telltale signs, and the triggers and catalysts behind it. Are you or someone you know struggling with age regression and its effects on mental health? Don't walk this path alone. MentalHealth's dedicated professional service can help you understand and cope with age regression, providing you with the support and guidance you need to live life to the fullest. Contact them today to take the first step towards a healthier and happier lifestyle.
Author Interviews, Mental Health Research, Pharmaceutical Companies / 14.01.2024

MedicalResearch.com Interview with: Lauren Davis Lauren C. Davis, MBS Department of Medical Education Geisinger Commonwealth School of Medicine Scranton, PA 19409   MedicalResearch.com: What is the background for this study? Response: Financial conflicts of interest (COIs) resulting from ties between academia and industry have been under scrutiny for their potential to hinder the integrity of medical research. COIs can lead to implicit bias, compromise the research process, and erode public trust (1-6). The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM), standardizes symptom criteria and codifies psychiatric disorders. This manual contributes to the approval of new drugs, extensions of patent exclusivity, and can influence payers and mental health professionals seeking third-party reimbursements. Given the implications of the DSM on public health, it is paramount that it is free of industry influence. Previous research has shown a high prevalence of industry ties among panel and task force members of the DSM-IV-TR and DSM-5, despite the implementation of a disclosure policy for the DSM-5 (7,8). This study (9) determined the extent and type of COIs received by panel and task-force members of the DSM-5-TR (2022) (10). As the DSM-5-TR did not disclose COI, we used the Center for Medicare and Medicaid Services Open Payments (OP) database (11) to quantify them.
Author Interviews, Brain Injury, Brigham & Women's - Harvard, Inflammation / 14.01.2024

MedicalResearch.com Interview with: [caption id="attachment_61250" align="alignleft" width="200"]Samir Mitragotri Ph.D.Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering Area Chair, Bioengineering Core Faculty Member, Wyss Institute for Biologically Inspired Engineering Harvard John A. Paulson School Of Engineering And Applied Sciences Prof. Mitragotri[/caption] Samir Mitragotri Ph.D. Hiller Professor of Bioengineering Hansjorg Wyss Professor of Biologically Inspired Engineering Area Chair, Bioengineering Core Faculty Member, Wyss Institute for Biologically Inspired Engineering Harvard John A. Paulson School Of Engineering And Applied Sciences MedicalResearch.com: What is the background for this study? Response: Traumatic brain injury (TBI) has a heavy burden on the world, affecting ~70 million people globally each year. Despite its prevalence, there are no clinically approved treatments beyond symptom management. There is an urgent need to develop effective therapies to alleviate the damage caused by TBI.   MedicalResearch.com:  What do macrophages typically do?  As part of the innate immune system, macrophages migrate to areas of injury to eat pathogens or debris and manage inflammation in response to injury or infection. However, in the majority of cases of TBI, there is no actual infection from a foreign pathogen, leading to excessive inflammation that spreads damage beyond the initial impact.
Author Interviews, Autism, JAMA, Pediatrics, Technology / 08.01.2024

MedicalResearch.com Interview with: Karen F. Heffler, MD Researcher, Autism Spectrum Disorder Associate Professor, Department of Psychiatry Drexel University College of Medicine Philadelphia, PA MedicalResearch.com: What is the background for this study? children-watching-tv-pexels-photo-4740522 Response: Atypical sensory processing is common in neurodevelopmental disorders, affecting approximately 60% of children with ADHD and up to 90% of children with autism. Sensory symptoms are associated with hyperactivity, restricted/repetitive behavior, irritability, behavioral problems, and emotional dysregulation. Sensory-related meltdowns and symptoms can be very disruptive to family-life, interfere with family participation in community events and are associated with increased caregiver stress. Prior to this study there was little understanding of potential risk factors for atypical sensory processing. The researchers used data from the National Children’s Study to determine the association between early-life screen time and sensory processing outcomes among toddlers.
Mental Health Research, Social Issues / 26.12.2023

In the fast-paced, interconnected world we now live in, the prevalence of burnout has become a concerning reality for many. The term was first coined in the 1970s to describe the chronic workplace stress that led to physical and emotional exhaustion. Since then, if you are feeling run down and exhausted you may well be yet another victim of modern-day fatigue. Here is a look at the nuances of burnout and some key factors contributing to this pervasive problem. Burnout goes beyond the workplace While burnout traditionally has its roots in a professional workplace setting, modern-day pressures means that the phenomenon now extends beyond the confines of the workplace. Burnout now encompasses a holistic exhaustion that permeates various aspects of life. These include personal relationships, social interactions, and even leisure activities. We have even reached a point where The World Health Organization (WHO) officially recognized burnout as a syndrome in the International Classification of Diseases, emphasizing its impact on overall well-being.
Alzheimer's - Dementia, Author Interviews, Weight Research / 28.11.2023

MedicalResearch.com Interview with:

[caption id="attachment_61098" align="alignleft" width="160"]Mahsa Dolatshahi, M.D., M.P.H.Post-doctoral research fellow Mallinckrodt Institute of Radiology (MIR) Washington University School of Medicine St. Louis Dr. Dolatshahi[/caption] Mahsa Dolatshahi, M.D., M.P.H. Post-doctoral research fellow Mallinckrodt Institute of Radiology (MIR) Washington University School of Medicine St. Louis MedicalResearch.com: What is the background for this study? Response: Obesity at midlife is recognized as a risk factor for developing Alzheimer disease decades afterwards. However, body mass index on its own does not adequately represent the risks associated with obesity. In this study, we went beyond BMI and considered anatomical distribution of body fat, including the metabolically active visceral fat in the belly, and showed its association with Alzheimer pathology in the form of amyloid proteins. In addition, visceral fat along with obesity and insulin resistance were associated with thinning of brain cortex, as early as midlife.
Author Interviews, Brain Injury / 16.11.2023

pexels-photo-7578808-medical-practitioner.webpIf you've been in a scrape and your noggin took a knock, playing it tough and shaking it off isn't the way to go. A traumatic brain injury (TBI), even one that seems no biggie, can be sneaky. At first, you might feel fine, but your brain's had a jolt, and it needs a look-over. Ignoring it? Bad move. That little headache or dizziness might be your brain's way of saying, "Hey, I'm not okay." Small signs like mood swings, sleep changes, or even just feeling "off" can be the early whispers of something bigger brewing. It's like ignoring a weird noise in your car's engine—let it go and you might just find yourself broken down on the highway of health.

The Domino Effect of Ignoring Symptoms

Let's talk about what happens if you shrug off those symptoms. A tiny injury can start a chain reaction. Before you know it, you could be dealing with big-time problems like memory issues, serious concentration hiccups, or even long-term disabilities. And here's the kicker: these troubles don't always show up on day one. They can sneak up on you, turning from "I'm fine" to "Why can't I remember my passwords?" in no time. Think about it—your brain runs the show, so even a small glitch can throw off the whole performance.
Alzheimer's - Dementia, Author Interviews, Genetic Research, JAMA, Stanford / 07.11.2023

MedicalResearch.com Interview with: [caption id="attachment_61020" align="alignleft" width="125"]MedicalResearch.com Interview with:Michael E. Belloy, PhD
Department of Neurology and Neurological Sciences
Stanford University, Stanford, California Dr. Belloy[/caption] Michael E. Belloy, PhD Department of Neurology and Neurological Sciences Stanford University, Stanford, California MedicalResearch.com: What is the background for this study? Response: Apolipoprotein E (APOE)*2 and APOE*4 are, respectively, the strongest protective and risk-increasing, genetic variants for late-onset Alzheimer disease. As such, one’s APOE genotype is highly relevant towards clinical trial design and Alzheimer’s disease research. However, most insights so far are focused on the associations of these APOE genotypes with Alzheimer’s disease risk in non-Hispanic white individuals. One important aspect of our work is that we really increased sample sizes for non-Hispanic Black, Hispanic, and East Asian individuals, so that we now have better understanding of the associations of APOE genotypes with Alzheimer’s disease risk in these groups. In complement, we also did the largest investigation to date on the role of ancestry on the associations of APOE genotypes with Alzheimer’s disease risk. The scale of our study was thus a critical factor in generating novel insights.
Author Interviews, Environmental Risks, JAMA, McGill, Mental Health Research / 06.11.2023

MedicalResearch.com Interview with: [caption id="attachment_60969" align="alignleft" width="150"]Niki Hosseini-Kamkar PhDPostdoc, McGill University Dr. Hosseini-Kamkar[/caption] Niki Hosseini-Kamkar PhD Postdoc, McGill University MedicalResearch.com: What is the background for this study? Response: Our primary question was: Do adults with a history of childhood trauma have altered brain responses to psychological challenges? Previous evidence indicated that this can occur in laboratory animals, but it has been unclear whether it occurs in humans.
Author Interviews, Cognitive Issues, Nature, Pediatrics / 01.11.2023

MedicalResearch.com Interview with: [caption id="attachment_60991" align="alignleft" width="150"]Brenden Tervo-Clemmens, Ph.D.Assistant Professor
Department of Psychiatry & Behavioral Sciences
Masonic Institute for the Developing Brain
Scholar, Institute for Translational Neuroscience
University of Minnesota Dr. Tervo-Clemmens[/caption] Brenden Tervo-Clemmens, Ph.D. Assistant Professor Department of Psychiatry & Behavioral Sciences Masonic Institute for the Developing Brain Scholar, Institute for Translational Neuroscience University of Minnesota MedicalResearch.com: What is the background for this study? Response:      Both contemporary and historical theories of neurobehavioral development suggest executive functions (EF) mature through adolescence. These are often used in various contexts to try to demarcate the developmental boundaries of the adolescent period. However, the specific maturational timing of executive function, and the independence of various potential executive function subcomponents remain unknown. Building from prior investigations with relatively small datasets or narrow subsets of executive function measures, this work using four independent datasets (N>10,000) and 17 distinct executive function assessments provides a precise charting, multi-assessment investigation, and replication of executive function development from adolescence to adulthood.
Author Interviews, Cognitive Issues, Exercise - Fitness, JAMA / 01.11.2023

MedicalResearch.com Interview with: [caption id="attachment_60958" align="alignleft" width="150"]Peter A. Harmer, PhD, MPH, AT-Ret, FACSMSenior Associate Research Scientist Oregon Research Institute Dr. Harmer[/caption] Peter A. Harmer, PhD, MPH, AT-Ret, FACSM Senior Associate Research Scientist Oregon Research Institute MedicalResearch.com: What is the background for this study? Response: Decline in various aspects of cognitive function, such as memory, executive function, and multitasking ability is common as we age. The rate and extent of decline varies among older adults but approximately 20% of those aged 65+ will experience clinically relevant mild cognitive impairment, which places them at increased risk of progressing to Alzheimer’s disease or related dementias. It is also associated with decreased mobility, increased risk of falls and impaired capacity for complex activities of daily living. Research has shown that physical and mental activity may attenuate the decline and that combined physical/mental challenges may be more effective than either alone but up to this point there has been little quality clinical evidence. Building on previous successful studies with our established tai ji quan therapy, we developed a cognitively-enhanced training tai ji quan protocol to determine its effectiveness in enhancing global cognition and dual-task walking compared to our standard tai ji quan program and a stretching program in adults 65+ with mild cognitive impairment or self-reported memory concerns.
Alzheimer's - Dementia, Author Interviews, Baylor College of Medicine Houston / 22.10.2023

MedicalResearch.com Interview with: [caption id="attachment_60949" align="alignleft" width="200"]David B. Corry, M.D.Professor of Pathology & Immunology and Medicine Vice Chair for Immunology Department of Pathology & Immunology Biology of Inflammation Center Dan L. Duncan Comprehensive Cancer Center   Clarence and Irene H. Fulbright Chair in Pathology Baylor College of Medicine Michael E. Debakey VA Medical Center Dr. Corry[/caption] David B. Corry, M.D. Professor of Pathology & Immunology and Medicine Vice Chair for Immunology Department of Pathology & Immunology Biology of Inflammation Center Dan L. Duncan Comprehensive Cancer Center   Clarence and Irene H. Fulbright Chair in Pathology Baylor College of Medicine Michael E. Debakey VA Medical Center MedicalResearch.com: What is the background for this study? Can candida species cross the blood brain barrier? Response: We showed earlier (2019) that the common fungus Candida albicans can enter the brain from the blood. That earlier study was in turn inspired by the finding of another research group that had found Candida in the brains of persons suffering from Alzheimer’s Disease and related dementing illnesses.
PTSD / 06.10.2023

Even when you have had the best military training available it is almost impossible to prepare your mind and body for the violence and traumatic experiences you might endure during active service. The threat of PTSD and other health issues is very real, such as veterans experiencing shell shock and still trying to process that experience many years later. Here is a look at some of the main health issues that a veteran might experience. Mental health challenges ptsd-veterans-warWearing the physical scars of war is just one side of the story. Many veterans can suffer significant mental health challenges long after they retire from active duty. The very real threat of Post Traumatic Stress Disorder (PTSD) has been well publicized in recent years. It is estimated that PTSD affects as many as 15% of veterans who fought in the Iraq war, for instance. Depression and alcohol abuse are other mental health issues faced by a percentage of veterans.
Accidents & Violence, ADHD, Author Interviews, Columbia, JAMA / 04.10.2023

[caption id="attachment_60891" align="alignleft" width="143"]Guohua Li, MD, DrPHFinster Professor of Epidemiology and Anesthesiology Columbia University Irving Medical Center Prof. Guohua Li[/caption] MedicalResearch.com Interview with: Guohua Li, MD, DrPH Finster Professor of Epidemiology and Anesthesiology Columbia University Irving Medical Center MedicalResearch.com: What is the background for this study? How was the ADHD diagnosis determined? Response: The reported prevalence of ADHD in children and young adults in the United States has more than doubled since the 1990s because of improved diagnosis.  Currently, ADHD affects about 13 percent of children under 18 years of age and eight percent of adults under 45 years of age.  Little is known about the prevalence of ADHD in older adults although it is estimated that ADHD symptoms may persist throughout the lifespan in about one-third of children diagnosed with the disorder.  Diagnostic criteria for adulthood ADHD include having five or more relevant symptoms, adverse impact on social, academic, and occupational activities,  and onset of symptoms before age 12. In this study, ADHD status is determined based on an affirmative response to the question of whether the participant had ever had ADHD or had ever been told by a doctor or other health professional that he or she had ADHD.
Accidents & Violence, Schizophrenia / 25.09.2023

Individuals suffering from mental health problems such as schizophrenia may utilize substances to deal with or cope with the issues they are experiencing. However, the abuse of substances can have a double effect on a person as it could complicate schizophrenia’s symptoms and potentially increase the likelihood of an individual experiencing or worsening symptoms. If your loved one is struggling with substance abuse and you fear this could cause or worsen mental health problems, you may consider taking them to a residential treatment near you to get professional assistance. Connection between Schizophrenia and Substance Abuse

addiction-schizophreniaOne of the most startling aspects of the connection between schizophrenia and substance abuse is the high prevalence of substance use disorders among those with schizophrenia. Studies consistently show that individuals diagnosed with schizophrenia are more likely to engage in substance abuse compared to the general population. This connection can be best demonstrated using the self-medication hypothesis.  According to this hypothesis, individuals with schizophrenia may turn to substances as a way to self-medicate or alleviate their distressing symptoms. Imagine dealing with hallucinations or disorganized thoughts—some may use alcohol or drugs to temporarily escape from this internal turmoil.

It is imperative to note that drug abuse does not in any way lead to schizophrenia. However, the misuse of drugs can be a catalyst if an individual is predisposed to the condition or if they are already experiencing mild symptoms.